Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: You would think

You would think

posted on Nov 02, 2007 10:09AM

since TPL has covered litigation news, on their website,  that a 30 day stay would be news-worthy. Would this also be considered worthy of a statement from PTSC to it's shareholders?

Looking for some clarification... with everyone else.

 

Share
New Message
Please login to post a reply